{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:28:48Z","timestamp":1791379728908,"version":"4.3.3"},"reference-count":16,"publisher":"MedWorks Media","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:p>Clozapine, amongst antipsychotics, has a unique composite mode of action that might translate into an expanded therapeutic potential on clinical grounds. Sorely, clozapine remains underutilized.<\/jats:p>","DOI":"10.64719\/pb.4490","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:39:16Z","timestamp":1761046756000},"page":"46-50","source":"Crossref","is-referenced-by-count":3,"title":["Clozapine Prescripers\u2014Dogmatic or Pragmatic?"],"prefix":"10.64719","volume":"54","author":[{"given":"Ahmed","family":"Naguy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessa","family":"Alhazeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Naguy A, Pridmore S, Singh A et al. Top-Up Clozapine for Risperidone LAI-Related Acute Dystonia and TR Bipolar in an Adolescent with ID\u2014Putting the Cart before the Horse. Psychopharmacol Bull. 2022;52(2):161\u2013164.","DOI":"10.64719\/pb.4438"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Naguy A, Alamiri B. Ultra-Treatment Resistant Schizophrenia\u2014Where Do We Stand. Asian J Psychiatr. 2019;44:95\u201396.","DOI":"10.1016\/j.ajp.2019.07.028"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Moodliar S, Naguy A, Elsori DH. Add-on mirtazapine to clozapine-responsive early-onset schizophrenia. Psychaitry Res. 2020;284:112701.","DOI":"10.1016\/j.psychres.2019.112701"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Arafat SMY, Rahman SMA, Haque MM et al. Clozapine Can Be the Good Option in Resistant Mania. Case Rep Psychiatry. 2016;2016:3081704.","DOI":"10.1155\/2016\/3081704"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Naguy A, Elbadry H, Salem H. Suicide: A Pr\u00e9cis. J Family Med Prim Care. 2020;9(8):4009\u20134015.","DOI":"10.4103\/jfmpc.jfmpc_12_20"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Naguy A, AlHumoud A. An octogenarian with Parkinson\u2019s disease psychosis that has responded favourably to low-dose sulpiride with facilitated motoric agility. Asian J Psychiatr. 2019;43:55\u201356.","DOI":"10.1016\/j.ajp.2019.05.001"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Howner K, Andine P, Engberg G et al. Pharmacological Treatment in Forensic Psychiatry-A Systematic Review. Front Psychaitry. 2020;10:963.","DOI":"10.3389\/fpsyt.2019.00963"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Mentzel TQ, van der Snoek R, Lieverse R et al. Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia: A Meta-Analysis. J Clin Psychaitry. 2018;79(6):17r11852.","DOI":"10.4088\/JCP.17r11852"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Beri A, Boydell J. Clozapine in borderline personality disorder: a review of the evidence. Ann Clin Psychaitry. 2014;26(2):139\u2013144.","DOI":"10.1177\/104012371402600207"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Rotharmel M, Szymoniak F, Pollet C et al. Eleven Years of Clozapine Experience in Autism Spectrum Disorder: Efficacy and Tolerance. J Clin Psychopharmacol. 2018;38(6):577\u2013581.","DOI":"10.1097\/JCP.0000000000000955"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Dadlani N, Small J, Starling J et al. Clozapine in the management of persistent destructive behaviour in a 17-year-old boy with intellectual disability. BMJ Case Rep. 2020;13(11):e235346.","DOI":"10.1136\/bcr-2020-235346"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Naguy A. Clonidine Use in Psychiatry: Panacea or Panache. Pharmacology. 2016;98(1\u20132):87\u201392.","DOI":"10.1159\/000446441"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Jeyapaul P, Vieweg R. A case study evaluating the use of clozapine in depression with psychotic features. Ann Gen Psychiatry. 2006;5(20)","DOI":"10.1186\/1744-859X-5-20"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Rafizadeh R, Danilewitz M, Bousman CA et al. Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis. J Psychopharmacol. 2023;37(2):135\u2013143.","DOI":"10.1177\/02698811221142575"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Miller BJ, McEvoy JP, McCall WV. Meta-analysis of clozapine and insomnia in schizophrenia. Schizophr Res. 2023;252:208\u2013215.","DOI":"10.1016\/j.schres.2023.01.018"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Yaw TK, Fox SH, Lang AE. Clozapine in Parkinsonian Rest Tremor: A Review of Outcomes, Adverse Reactions, and Possible Mechanisms of Action. Mov Disord Clin Pract. 2016;3(2):116\u2013124.","DOI":"10.1002\/mdc3.12266"}],"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:32:29Z","timestamp":1791315149000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/clozapine-prescripers-dogmatic-or-pragmatic\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8,12]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.4490","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}